LLY

729.6

+0.49%↑

UNH

520.01

+2.09%↑

JNJ

147.92

+0.64%↑

ABBV

172.46

+0.64%↑

NVO

80.13

+1.78%↑

LLY

729.6

+0.49%↑

UNH

520.01

+2.09%↑

JNJ

147.92

+0.64%↑

ABBV

172.46

+0.64%↑

NVO

80.13

+1.78%↑

LLY

729.6

+0.49%↑

UNH

520.01

+2.09%↑

JNJ

147.92

+0.64%↑

ABBV

172.46

+0.64%↑

NVO

80.13

+1.78%↑

LLY

729.6

+0.49%↑

UNH

520.01

+2.09%↑

JNJ

147.92

+0.64%↑

ABBV

172.46

+0.64%↑

NVO

80.13

+1.78%↑

LLY

729.6

+0.49%↑

UNH

520.01

+2.09%↑

JNJ

147.92

+0.64%↑

ABBV

172.46

+0.64%↑

NVO

80.13

+1.78%↑

Search

Abbott Laboratories

Cerrado

Sector Salud

113.37 -0.49

Resumen

Variación precio

24h

Actual

Mínimo

113.22

Máximo

114.68

Métricas clave

By Trading Economics

Ingresos

344M

1.6B

Ventas

220M

11B

P/B

Media del Sector

32.37

59.974

BPA

1.21

Rentabilidad por dividendo

1.93

Margen de beneficio

15.528

EBITDA

-153M

2.4B

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

+21.9 upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

1.93%

2.29%

Próximas Ganancias

22 ene 2025

Fecha Próximo Dividendo

14 feb 2025

Próxima Fecha de Ex Dividendo

11 abr 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-278M

196B

Apertura anterior

113.86

Cierre anterior

113.37

Noticias sobre sentimiento de mercado

By Acuity

35%

65%

107 / 392 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

Abbott Laboratories Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

1 nov 2024, 14:15 UTC

Principales Movimientos del Mercado

Reckitt, Abbott Shares Rise After Baby-Formula Lawsuit Win -- Update

1 nov 2024, 10:10 UTC

Principales Movimientos del Mercado

Reckitt Shares Surge After Baby Formula Lawsuit Win

31 oct 2024, 23:57 UTC

Acciones populares

Stocks to Watch: Intel, Amazon.com, Abbott Laboratories, MasTec

31 oct 2024, 23:14 UTC

Principales Movimientos del Mercado

Abbott Laboratories Shares Rise After Baby-Formula Verdict

16 oct 2024, 12:03 UTC

Ganancias

Abbott Laboratories 3Q Sales Top Expectations

29 jul 2024, 10:30 UTC

Principales Movimientos del Mercado

Abbott Laboratories Shares Tumble on $495 Million Infant Formula Verdict

29 jul 2024, 09:27 UTC

Principales Movimientos del Mercado

Reckitt Benckiser Shares Tumble on Abbott's Baby-Formula Litigation

18 jul 2024, 12:21 UTC

Ganancias

Abbott Labs Lifts FY24 Outlook After 2Q Sales Rise

1 nov 2024, 17:33 UTC

Charlas de Mercado

Abbott's Baby-Formula Lawsuit Win Could Decrease Liabilities -- Market Talk

16 oct 2024, 14:21 UTC

Principales Noticias
Ganancias

Abbott Posts Solid Quarter. The Stock Is Rising. -- Barrons.com

16 oct 2024, 12:25 UTC

Ganancias

Abbott Labs Beats Q3 Sales And Earnings Expectations, Raises Full-Year Outlook -- MarketWatch

16 oct 2024, 12:02 UTC

Principales Noticias
Ganancias

Abbott Posts Solid Quarter. That Wasn't Enough to Lift Shares. -- Barrons.com

16 oct 2024, 11:59 UTC

Ganancias

Abbott Earnings Edge Past Q3 Views, Led By Medical Devices -- IBD

16 oct 2024, 11:37 UTC

Ganancias

Abbott Labs Sees 4Q Adj EPS $1.31-Adj EPS $1.37 >ABT

16 oct 2024, 11:36 UTC

Ganancias

Abbott Labs Sees 4Q EPS 96c-EPS $1.02 >ABT

16 oct 2024, 11:35 UTC

Ganancias

Abbott Labs: Well-positioned to Achieve Upper End of Our Initial Guidance Ranges for Yr and Have Great Momentum Heading Into Next Yr >ABT

16 oct 2024, 11:35 UTC

Ganancias

Abbott Labs Maintains Full-Yr 2024 Organic Sales Growth Guidance Range of 9.5% to 10.0%, Excluding COVID-19 Testing-Related Sales >ABT

16 oct 2024, 11:30 UTC

Ganancias

Abbott Labs 3Q Organic Sales Growth Up 7.6% >ABT

16 oct 2024, 11:30 UTC

Ganancias

Abbott Labs 3Q Sales $10.64B >ABT

16 oct 2024, 11:30 UTC

Ganancias

Abbott Labs 3Q Net $1.65B >ABT

16 oct 2024, 11:30 UTC

Ganancias

Abbott Labs 3Q Adj EPS $1.21 >ABT

16 oct 2024, 11:30 UTC

Ganancias

Abbott Labs Sees FY Adj EPS $4.64-Adj EPS $4.70 >ABT

16 oct 2024, 11:30 UTC

Ganancias

Abbott Labs Sees FY EPS $3.34-EPS $3.40 >ABT

16 oct 2024, 11:30 UTC

Ganancias

Abbott Labs 3Q EPS 94c >ABT

29 jul 2024, 10:15 UTC

Principales Movimientos del Mercado

Abbott Laboratories Shares Tumble on $495 Mln Infant Formula Verdict

29 jul 2024, 08:50 UTC

Acciones populares

Stocks to Watch Monday: Coinbase, Abbott, McDonald's, Heineken -- WSJ

18 jul 2024, 19:04 UTC

Charlas de Mercado
Ganancias

Abbott CEO Warns of Health Crisis if Preterm Formula Pulled -- Market Talk

18 jul 2024, 11:43 UTC

Ganancias

Abbott Laboratories Earnings Top Views, Full-Year Guidance Raised -- IBD

18 jul 2024, 11:34 UTC

Ganancias

Abbott Labs Sees 3Q Adj EPS $1.18-Adj EPS $1.22 >ABT

18 jul 2024, 11:34 UTC

Ganancias

Abbott Labs Sees 3Q EPS 85c-EPS 89c >ABT

Comparación entre iguales

Cambio de precio

Abbott Laboratories Esperado

Precio Objetivo

By TipRanks

21.9% repunte

Estimación a 12 meses

Media 135.43 USD  21.9%

Máximo 149 USD

Mínimo 117 USD

De acuerdo con 15 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Abbott Laboratories Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

15 ratings

13

Comprar

2

Mantener

0

Vender

Puntuación técnica

By Trading Central

113.44 / 113.96Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

Weak Bullish Evidence

Sentimiento

By Acuity

107 / 392 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Abbott Laboratories

Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its products include a line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The Company’s products are sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses. It offers cardiovascular and metabolic products, including Lipanthyl, TriCor, Teveten, Teveten Plus, Physiotens, and Synthroid.